Literature DB >> 12640134

Dissecting the contribution of p16(INK4A) and the Rb family to the Ras transformed phenotype.

Philip J Mitchell1, Elena Perez-Nadales, Denise S Malcolm, Alison C Lloyd.   

Abstract

Although oncogenic Ras commonly contributes to the development of cancer, in normal primary cells it induces cell cycle arrest rather than transformation. Here we analyze the additional genetic changes required for Ras to promote cell cycle progression rather than arrest. We show that loss of p53 is sufficient for oncogenic Ras to stimulate proliferation in the absence of extrinsic mitogens in attached cells. However, surprisingly, we find that p53 loss is not sufficient for Ras to overcome anchorage dependence or contact inhibition. In contrast, expression of simian virus 40 (SV40) large T antigen (LT) allows Ras to overcome these additional cell cycle controls. Mutational analysis of SV40 LT shows that this action of SV40 LT depends on its ability to inactivate the retinoblastoma (Rb) family of proteins, in concert with the loss of p53. Importantly, we show that inactivation of the Rb family of proteins can be mimicked by loss of the cyclin-dependent kinase inhibitor p16(INK4A). p16(INK4A) is commonly lost in human tumors, but its contribution to the transformed phenotype is unknown. We demonstrate here a role for p16(INK4A) in the loss of cell cycle controls required for tumorigenesis and show how accumulating genetic changes cooperate and contribute to the transformed phenotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640134      PMCID: PMC150721          DOI: 10.1128/MCB.23.7.2530-2542.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

Review 1.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

2.  The J domain of simian virus 40 large T antigen is required to functionally inactivate RB family proteins.

Authors:  J Zalvide; H Stubdal; J A DeCaprio
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

3.  Inactivation of pRB-related proteins p130 and p107 mediated by the J domain of simian virus 40 large T antigen.

Authors:  H Stubdal; J Zalvide; K S Campbell; C Schweitzer; T M Roberts; J A DeCaprio
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells.

Authors:  S Cowley; H Paterson; P Kemp; C J Marshall
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

5.  Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

Authors:  M Schutte; R H Hruban; J Geradts; R Maynard; W Hilgers; S K Rabindran; C A Moskaluk; S A Hahn; I Schwarte-Waldhoff; W Schmiegel; S B Baylin; S E Kern; J G Herman
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

6.  Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

Authors:  T Kamijo; F Zindy; M F Roussel; D E Quelle; J R Downing; R A Ashmun; G Grosveld; C J Sherr
Journal:  Cell       Date:  1997-11-28       Impact factor: 41.582

7.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

8.  Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor.

Authors:  E Castaño; Y Kleyner; B D Dynlacht
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

9.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

10.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

Authors:  T Kamijo; J D Weber; G Zambetti; F Zindy; M F Roussel; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more
  10 in total

1.  The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation.

Authors:  Marie C Harrisingh; Elena Perez-Nadales; David B Parkinson; Denise S Malcolm; Anne W Mudge; Alison C Lloyd
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

Review 2.  Surprising dependency for retinoblastoma protein in ras-mediated tumorigenesis.

Authors:  James DeGregori
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  Critical and distinct roles of p16 and telomerase in regulating the proliferative life span of normal human prostate epithelial progenitor cells.

Authors:  Bobby Bhatia; Ming Jiang; Mahipal Suraneni; Lubna Patrawala; Mark Badeaux; Robin Schneider-Broussard; Asha S Multani; Collene R Jeter; Tammy Calhoun-Davis; Limei Hu; Jianhua Hu; Spiridon Tsavachidis; Wei Zhang; Sandy Chang; Simon W Hayward; Dean G Tang
Journal:  J Biol Chem       Date:  2008-07-28       Impact factor: 5.157

4.  Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma.

Authors:  Anupam Mishra; Subhash Chandra Mishra; Ashoak Mani Tripathi; Amita Pandey
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-31       Impact factor: 2.503

5.  The retinoblastoma protein is required for Ras-induced oncogenic transformation.

Authors:  Jonathan P Williams; Timothy Stewart; Bihua Li; Roseann Mulloy; Dessislava Dimova; Marie Classon
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

6.  NF1 loss disrupts Schwann cell-axonal interactions: a novel role for semaphorin 4F.

Authors:  Simona Parrinello; Luke A Noon; Marie C Harrisingh; Patrick Wingfield Digby; Laura H Rosenberg; Catherine A Cremona; Pedro Echave; Adrienne M Flanagan; Luis F Parada; Alison C Lloyd
Journal:  Genes Dev       Date:  2008-12-01       Impact factor: 11.361

7.  A genetic screen for anchorage-independent proliferation in mammalian cells identifies a membrane-bound neuregulin.

Authors:  Davide Danovi; Catherine A Cremona; Gisela Machado-da-Silva; Sreya Basu; Luke A Noon; Simona Parrinello; Alison C Lloyd
Journal:  PLoS One       Date:  2010-07-26       Impact factor: 3.240

8.  Loss of anchorage in checkpoint-deficient cells increases genomic instability and promotes oncogenic transformation.

Authors:  Catherine A Cremona; Alison C Lloyd
Journal:  J Cell Sci       Date:  2009-08-18       Impact factor: 5.285

9.  HDAC3 Regulates the Transition to the Homeostatic Myelinating Schwann Cell State.

Authors:  Laura H Rosenberg; Anne-Laure Cattin; Xavier Fontana; Elizabeth Harford-Wright; Jemima J Burden; Ian J White; Jacob G Smith; Ilaria Napoli; Victor Quereda; Cristina Policarpi; Jamie Freeman; Robin Ketteler; Antonella Riccio; Alison C Lloyd
Journal:  Cell Rep       Date:  2018-12-04       Impact factor: 9.423

10.  Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort.

Authors:  Marina Kvaskoff; Anne Bijon; Sylvie Mesrine; Alice Vilier; Laura Baglietto; Agnès Fournier; Françoise Clavel-Chapelon; Laure Dossus; Marie-Christine Boutron-Ruault
Journal:  PLoS Med       Date:  2014-06-10       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.